Stock listing

BOATS:RXST RxSight, Inc. Stock

US listing (BOATS) of RxSight, Inc. · home listing NASDAQ:RXST

Follow RxSight, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:RXST

$4.47 USD -0.54 (-10.8%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:RXST

Past year -50.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$4.45 – $4.75 USDNov 20, 2026
Volume
539,306 sharesNov 20, 2026
Market cap
$187.4M USDAt the close on Nov 20, 2026 · price × 41.93M shares outstanding
52-week range
$4.11 – $13.22 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$4.43M USDMedian day 743,694 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
RxSight, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:RXST · Home$4.47 USD-0.54 (-10.8%)539,306$4.56$4.751$4.45$5.01Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:RXST · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$4.47-0.54-10.8%$4.56$4.751$4.45539,306
$5.01+0.18+3.7%$4.82$5.07$4.80736,093
$4.83-0.47-8.9%$5.26$5.29$4.7051,025,747
$5.30-0.02-0.4%$5.31$5.43$5.181,002,248
$5.32-0.06-1.1%$5.45$5.63$5.29534,549
$5.38+0.10+1.9%$5.25$5.50$5.04963,002
$5.28+0.38+7.8%$4.87$5.29$4.84808,160
$4.90+0.04+0.8%$4.81$5.12$4.741,082,341
$4.86+0.32+7.0%$4.61$4.96$4.5851,868,627
$4.540.000.0%$4.55$4.60$4.36948,254
$4.54-0.45-9.0%$5.05$5.135$4.401,494,802
$4.99+0.40+8.7%$4.11$5.445$4.112,753,287
$4.59-0.21-4.4%$4.78$4.78$4.5451,196,930
$4.80-0.07-1.4%$4.91$5.01$4.79757,418
$4.87-0.18-3.6%$5.06$5.065$4.845468,434
$5.05+0.15+3.1%$4.97$5.19$4.92841,601
$4.900.000.0%$4.76$4.94$4.75787,843
$4.90-0.03-0.6%$4.97$5.045$4.87588,689
$4.93-0.09-1.8%$4.97$5.095$4.889451,460
$5.02-0.06-1.2%$5.07$5.105$5.01326,804
$5.08+0.18+3.7%$4.89$5.09$4.84393,229
$4.90+0.02+0.4%$4.87$5.04$4.77577,115
$4.88+0.19+4.1%$4.71$4.92$4.65453,924
$4.69+0.18+4.0%$4.46$4.77$4.45743,694
$4.51-0.16-3.4%$4.70$4.83$4.4951,041,021
$4.67+0.15+3.3%$4.59$4.71$4.55611,173
$4.52-0.01-0.2%$4.46$4.55$4.40826,701
$4.53-0.13-2.8%$4.68$4.77$4.445694,860
$4.66-0.15-3.1%$4.85$4.98$4.55834,560
$4.81-0.04-0.8%$4.83$4.94$4.75522,336
$4.85+0.05+1.0%$4.74$4.86$4.68938,305
$4.80+0.15+3.2%$4.61$4.95$4.61842,152
$4.65-0.11-2.3%$4.76$4.76$4.60623,009
$4.76+0.08+1.7%$4.70$4.805$4.62483,757
$4.68-0.07-1.5%$4.75$4.77$4.63616,825
$4.75-0.15-3.1%$4.88$4.89$4.74508,921
$4.90+0.13+2.7%$4.80$4.99$4.67705,661
$4.77+0.10+2.1%$4.67$4.78$4.62810,925
$4.67+0.01+0.2%$4.67$4.78$4.611,023,181
$4.66-0.07-1.5%$4.72$4.78$4.631,118,853
$4.73-0.12-2.5%$4.85$4.91$4.671,219,275
$4.85-0.08-1.6%$4.90$4.985$4.84593,514
$4.93-0.21-4.1%$5.05$5.16$4.90849,601
$5.14-0.06-1.2%$5.21$5.34$5.05627,678
$5.20-0.12-2.3%$5.25$5.363$5.1651,077,975
$5.32-0.08-1.5%$5.58$5.58$5.171,011,866
$5.40-0.22-3.9%$5.56$5.58$5.31802,962
$5.62-0.485-7.9%$6.05$6.05$5.60679,268
$6.105+0.085+1.4%$6.02$6.21$5.955632,159
$6.02+0.06+1.0%$6.00$6.025$5.78450,645
$5.96-0.37-5.8%$6.26$6.325$5.89667,392
$6.33-0.12-1.9%$6.41$6.655$6.2651,206,647
$6.45+0.075+1.2%$6.28$6.47$6.05734,193
$6.375-0.165-2.5%$6.47$6.63$6.34561,298
$6.54-0.49-7.0%$7.11$7.11$6.48605,386
$7.03+0.04+0.6%$6.96$7.345$6.909778,866
$6.99-0.34-4.6%$7.28$7.44$6.955988,922
$7.33+0.28+4.0%$7.05$7.36$7.001,289,585
$7.05+0.44+6.7%$6.59$7.06$6.55663,403
$6.61+0.23+3.6%$6.36$6.69$6.27580,116
$6.38-0.02-0.3%$6.36$6.61$6.1851,720,603
$6.40+0.14+2.2%$6.23$6.41$6.14366,354
$6.26+0.01+0.2%$6.26$6.55$6.184480,561
$6.25+0.16+2.6%$6.10$6.31$6.001,544,598
$6.09-0.07-1.1%$6.09$6.245$5.945663,004
Ticker
BOATS:RXST
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
BOATS
Currency
USD

What changed lately

Latest news

All RxSight, Inc. news

RxSight, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
20 in the last 12 months · 95 in all · newest Nov 19, 2026 · oldest 2021
Calls
22 calls with a replay · 22 with a transcript · latest Nov 3, 2026
Decks
4 decks · latest August 2026

Where RxSight, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:RXST · Home listingNASDAQUnited StatesUSD
BOATS:RXST · This pageBOATSUnited StatesUSD

Valuation

EV/sales −0.5× against a median of 2.3×: the lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$56.94M USD
P/E
Loss
EV/sales
−0.5×
EV/EBITDA
Negative EBITDA
Price/book
0.7×
Gross margin
76.1%
Operating margin
−50.4%
Net margin
−43.8%
Debt to equity
0.0×
Beta vs S&P 500
1.44

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
RxSight, Inc. · NASDAQ:RXSTUS$187.4M−US$56.94Mn/a−0.5×n/a0.7×−43.8%0.0×1.44
Pro-Dex, Inc. · NASDAQ:PDEXUS$203.7MUS$190.7M16.9×2.4×n/a4.1×15.1%0.0×1.15
AOTI, Inc. · LSE:AOTIUS$201.3MUS$208.6Mn/an/an/a9.6×n/a1.0×n/a
United Orthopedic Corporation · TPEX:4129US$196.0MUS$201.9M11.7×1.1×5.2×1.7×9.1%0.2×n/a
Electromed, Inc. · AMEX:ELMDUS$190.4MUS$174.6M16.0×2.3×11.1×3.6×15.8%0.0×0.62
Shanghai Heartcare Medical Technology Corp. Ltd. Class H · HKEX:6609US$190.2MUS$78.11M13.7×1.0×4.3×1.0×18.1%0.0×n/a
Angel Robotics Co., Ltd. · KRX:455900US$188.8MUS$169.5Mn/a67.6×n/a8.2×−266.0%0.0×n/a
Value Added Technology Co., Ltd. · KRX:043150US$181.9MUS$69.59M4.3×0.2×1.2×0.5×13.0%0.0×n/a
Medeon Biodesign, Inc. · TPEX:6499US$178.3MUS$149.1Mn/a11.7×n/a4.8×−159.3%0.0×n/a
Anika Therapeutics Inc. · NASDAQ:ANIKUS$177.2MUS$156.8Mn/a1.3×51.7×1.3×−1.4%0.2×0.68
Guangdong True Health Medical Technology Development Co. Ltd. Class H · HKEX:2697US$169.6MUS$96.20Mn/a52.7×n/a2.1×−740.0%0.0×n/a
Median of the othersUS$189.5MUS$163.1M13.7×2.3×5.2×2.9×9.1%0.0×0.68

Forecasts

1 buy · 7 hold · 2 sell · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
6.10 USD · Analysts' mean
EPS, year to Dec 2026
-0.13 · 3 analysts
Revenue, year to Dec 2026
146.8M · 10 analysts

Team and board

Officers

OfficerRole
Aziz MottiwalaPresident and Chief Executive Officer
Mark WilterdingChief Financial Officer
Ilya GoldshlegerChief Operating Officer
Jim SchindlerExecutive Vice President & General Counsel
Oliver MoravcevicInvestor Relations
Frank ShieldsExecutive Vice President, Sales & Commercial Strategy
Maureen O’ConnellExecutive Vice President, Clinical & Regulatory Affairs
Patrick CullenExecutive Vice President, Quality & Infrastructure Operations
Eric WeinbergChief Business Development Officer
Ron KurtzChief Medical Officer
Taryn ConwayChief Commercial Officer

Board

DirectorRole
J. Andy CorleyChairman
Aziz MottiwalaPresident and Chief Executive Officer
Julie B. AndrewsDirector
Juliet Tammenoms BakkerDirector
Robert J. PalmisanoDirector
Robert WarnerDirector
Shweta Singh ManiarDirector
Tamara R. FountainDirector
William J. LinkDirector

Events

Calls

CallWhenStatus
RxSight (NASDAQ:RXST) Q3 2026 Earnings CallTue, Nov 03, 2026 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q2 2026 Earnings CallTue, Jul 07, 2026 · 8:00 AM ETReplay
RxSight (NASDAQ:RXST) Q1 2026 Earnings CallWed, May 06, 2026 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q4 2025 Earnings CallWed, Feb 25, 2026 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q3 2025 Earnings CallWed, Nov 05, 2025 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q2 2025 Earnings CallThu, Aug 07, 2025 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q1 2025 Earnings CallWed, May 07, 2025 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q4 2024 Earnings CallTue, Feb 25, 2025 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q3 2024 Earnings CallSat, Nov 09, 2024 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q2 2024 Earnings CallMon, Aug 05, 2024 · 4:30 PM ETReplay
All 22 calls
CallWhenStatus
RxSight (NASDAQ:RXST) Q1 2024 Earnings CallMon, May 06, 2024 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q4 2023 Earnings CallWed, Feb 28, 2024 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q3 2023 Earnings CallThu, Nov 09, 2023 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q2 2023 Earnings CallMon, Aug 07, 2023 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q1 2023 Earnings CallTue, May 09, 2023 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q4 2022 Earnings CallMon, Mar 06, 2023 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q3 2022 Earnings CallMon, Nov 07, 2022 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q2 2022 Earnings CallMon, Aug 08, 2022 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q1 2022 Earnings CallThu, May 05, 2022 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q4 2021 Earnings CallTue, Mar 08, 2022 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q3 2021 Earnings CallWed, Nov 10, 2021 · 4:30 PM ETReplay
RxSight (NASDAQ:RXST) Q2 2021 Earnings CallThu, Sep 09, 2021 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 3, 2026 · After close+8.7%
Q2 2026Aug 5, 2026 · After close−3.3%
Q1 2026May 6, 2026 · After close−14.4%
Q4 2025Mar 10, 2026−2.4%
Q3 2025Nov 5, 2025 · After close+3.2%
Q2 2025Aug 7, 2025 · After close−7.7%
Q1 2025May 7, 2025 · After close−11.2%
Q4 2024Feb 25, 2025−1.1%
Q3 2024Nov 7, 2024 · After close−5.6%
Q2 2024Aug 5, 2024 · After close+17.3%
All 20 quarters
QuarterResultsShare move
Q1 2024May 6, 2024 · After close−1.0%
Q4 2023Feb 28, 2024 · After close−3.2%
Q3 2023Nov 9, 2023 · After close+6.2%
Q2 2023Aug 7, 2023 · After close+2.7%
Q1 2023May 9, 2023 · After close+9.9%
Q4 2022Mar 6, 2023 · After close−2.9%
Q3 2022Nov 7, 2022 · After close+6.7%
Q2 2022Aug 8, 2022 · After close−2.6%
Q1 2022May 5, 2022 · After close+7.0%
Q4 2021Mar 8, 2022 · After close+11.1%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (August 2026)Investor deck14 slidesAugust 2026
Q2 2026 Earnings PresentationEarnings14 slidesJul 7, 2026
Q4 2025 Earnings PresentationEarnings16 slidesFeb 25, 2026
Investor Presentation (January 2026)Investor deck16 slidesJanuary 2026

Open Decks

IPO

Priced at US$16.00 a share on Jul 29, 2021.

Price
US$16.00 a share
Shares offered
7,350,000 shares of common stock
Offering size
US$117.6 million
Underwriters' option
Up to 1,102,500 more shares
Underwriters
J.P. Morgan, BofA Securities, SVB Leerink, Wells Fargo Securities, BTIG · In the order on the cover
Shares delivered
On or about Aug 3, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceMay 17, 2021
Filed publiclyJul 9, 2021
Amended twiceNewest Jul 28, 2021
Shares registered with an exchangeJul 28, 2021
Declared effective by the SECJul 29, 2021
Final prospectus, with the priceJul 30, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Jul 30, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue134.5M139.9M89.1M49.0M22.6M14.7M2.24M
Cost of revenue31.5M41.0M35.3M27.7M18.1M13.0M4.06M
Gross profit103.0M98.9M53.8M21.3M4.52M1.71M-1.82M
Research and development38.5M34.4M29.1M26.0M24.5M21.9M29.6M
Selling, general and administrative112.7M101.4M74.8M58.7M32.8M15.2M15.2M
Operating income-48.2M-36.9M-50.1M-63.3M-52.8M-35.4M-46.1M
Depreciation and amortization3.27M3.58M4.08M3.88M3.98M3.85M3.93M
EBITDA-44.9M-33.3M-46.0M-59.4M-48.8M-31.6M-42.1M
Interest expense19.0K21.0K3.31M4.95M3.68M510.0K26.0K
Income before tax-38.9M-27.4M-48.6M-66.7M-48.7M27.6M126.2M
Income tax66.0K50.0K20.0K9.00K8.00K57.0K24.0K
Net income-38.9M-27.5M-48.6M-66.8M-48.7M27.6M126.2M
Earnings per share, basic-0.95-0.71-1.41-2.41-3.570.916.62
Earnings per share, diluted-0.95-0.71-1.41-2.41-3.570.15

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents19.9M16.7M9.69M11.8M24.4M14.0M7.96M
Short-term investments208.2M220.5M117.5M94.0M135.0M55.0M72.7M
Receivables23.4M30.1M20.3M11.0M4.86M2.87M789.0K
Inventory31.6M22.0M17.4M14.8M8.03M8.29M7.22M
Current assets287.5M293.8M168.4M134.6M176.3M81.5M90.2M
Property, plant and equipment13.1M12.4M10.8M10.1M11.2M13.3M19.3M
Total assets311.8M318.6M182.6M150.2M192.7M100.7M110.4M
Accounts payable5.30M4.54M3.86M2.60M1.69M1.13M2.20M
Current liabilities26.3M25.9M20.9M17.2M11.1M11.6M8.46M
Long-term debt40.2M43.4M24.4M
Total debt11.0M12.3M040.2M39.8M24.4M5.52M
Total liabilities36.1M37.3M22.2M60.3M54.5M44.9M415.0M
Shareholders' equity275.7M281.2M160.4M89.9M138.2M-430.6M-304.6M
Shares outstanding41.2M40.4M36.1M28.3M27.4M27.4M19.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-15.5M-16.9M-41.6M-58.9M-44.7M-35.2M-40.6M
Capital spending-3.83M-5.44M-4.81M-2.39M-1.94M-2.54M-4.09M
Free cash flow-19.3M-22.4M-46.4M-61.2M-46.6M-37.7M-44.7M
Cash from investing16.9M-99.3M-22.1M40.0M-81.9M15.6M-5.87M
Cash from financing1.86M123.3M61.5M6.33M137.3M25.2M1.33M
Dividends paid-643.0K
Share buybacks-1.42M-643.0K121.9M
Change in cash3.24M7.05M-2.19M-12.6M10.7M5.63M-45.2M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 10, 2026Big-stake noticeSEC
S-8 · Registration statement for employee plansNov 3, 2026Offer documentSEC
10-Q · Quarterly reportNov 3, 2026Quarterly reportSEC
8-K · Current reportNov 3, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 2, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 27, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 27, 2026Big-stake noticeSEC
4 · Change in ownershipSep 16, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
SC TO-I/ASep 8, 2026Acquisition or disposalSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
SC TO-I/AAug 24, 2026Acquisition or disposalSEC
SCHEDULE 13G · Big-stake noticeAug 19, 2026Big-stake noticeSEC
144 · Notice of proposed saleAug 18, 2026Other filingsSEC
SC TO-IAug 10, 2026Acquisition or disposalSEC
10-Q · Quarterly reportAug 5, 2026Quarterly reportSEC
8-K · Current reportAug 5, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 4, 2026Big-stake noticeSEC
4 · Change in ownershipJul 24, 2026Insider tradeSEC
3 · Initial statement of ownershipJul 24, 2026Insider tradeSEC
S-8 · Registration statement for employee plansJul 23, 2026Offer documentSEC
SCHEDULE 13G · Big-stake noticeJul 17, 2026Big-stake noticeSEC
8-K · Current reportJul 15, 2026Management or board changeSEC
8-K · Current reportJul 6, 2026ResultsSEC
8-K · Current reportJul 6, 2026Material contractSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
8-K · Current reportJun 16, 2026Meeting outcomeSEC
SD · Specialized disclosureMay 29, 2026ESG reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 13, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K · Current reportMay 6, 2026ResultsSEC
ARS · Annual report to shareholdersApr 28, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 28, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 28, 2026Meeting noticeSEC
4 · Change in ownershipApr 20, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
8-K/A · Current report, amendedMar 19, 2026Management or board changeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveFeb 27, 2026Other filingsSEC
POS AM · Amendment to an effective registrationFeb 25, 2026Offer documentSEC
S-8 · Registration statement for employee plansFeb 25, 2026Offer documentSEC
10-K · Annual reportFeb 25, 2026Annual reportSEC
8-K · Current reportFeb 25, 2026ResultsSEC
POSASRFeb 13, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeFeb 3, 2026Big-stake noticeSEC
4 · Change in ownershipJan 30, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 30, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 15, 2026Insider tradeSEC
8-K · Current reportJan 12, 2026ResultsSEC
8-K · Current reportDec 23, 2025Management or board changeSEC
8-K · Current reportDec 22, 2025Management or board changeSEC
8-K · Current reportDec 19, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 12, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 4, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 17, 2025Big-stake noticeSEC
4 · Change in ownershipSep 26, 2025Insider tradeSEC
8-K/A · Current report, amendedAug 15, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 12, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
8-K · Current reportAug 7, 2025ResultsSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
3 · Initial statement of ownershipAug 4, 2025Insider tradeSEC
8-K · Current reportAug 4, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeJul 15, 2025Big-stake noticeSEC
8-K · Current reportJul 8, 2025ResultsSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
8-K · Current reportJun 4, 2025Meeting outcomeSEC
4 · Change in ownershipJun 3, 2025Insider tradeSEC
SD · Specialized disclosureMay 20, 2025ESG reportSEC
10-Q · Quarterly reportMay 7, 2025Quarterly reportSEC
8-K · Current reportMay 7, 2025ResultsSEC
DEF 14A · Proxy statementApr 21, 2025Meeting noticeSEC
ARS/A · Annual report to shareholders, amendedApr 21, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 21, 2025Meeting noticeSEC
4 · Change in ownershipApr 15, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeApr 8, 2025Big-stake noticeSEC
8-K · Current reportApr 2, 2025ResultsSEC
4 · Change in ownershipMar 13, 2025Insider tradeSEC
144 · Notice of proposed saleMar 12, 2025Other filingsSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
S-8 · Registration statement for employee plansFeb 25, 2025Offer documentSEC
10-K · Annual reportFeb 25, 2025Annual reportSEC
8-K · Current reportFeb 25, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2025Big-stake noticeSEC
4 · Change in ownershipJan 27, 2025Insider tradeSEC
144 · Notice of proposed saleJan 22, 2025Other filingsSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
8-K · Current reportJan 13, 2025ResultsSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
144 · Notice of proposed saleNov 29, 2024Other filingsSEC
4 · Change in ownershipNov 26, 2024Insider tradeSEC
4 · Change in ownershipNov 26, 2024Insider tradeSEC
144 · Notice of proposed saleNov 26, 2024Other filingsSEC
144 · Notice of proposed saleNov 26, 2024Other filingsSEC
144 · Notice of proposed saleNov 22, 2024Other filingsSEC
4 · Change in ownershipNov 18, 2024Insider tradeSEC
144 · Notice of proposed saleNov 18, 2024Other filingsSEC
144 · Notice of proposed saleNov 15, 2024Other filingsSEC
4 · Change in ownershipNov 14, 2024Insider tradeSEC
4 · Change in ownershipNov 14, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
144 · Notice of proposed saleNov 12, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 12, 2024Big-stake noticeSEC
4 · Change in ownershipNov 8, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 8, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
144 · Notice of proposed saleNov 7, 2024Other filingsSEC
8-K · Current reportNov 7, 2024ResultsSEC
4 · Change in ownershipNov 5, 2024Insider tradeSEC
144 · Notice of proposed saleNov 4, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 4, 2024Big-stake noticeSEC
4 · Change in ownershipOct 31, 2024Insider tradeSEC
144 · Notice of proposed saleOct 30, 2024Other filingsSEC
4 · Change in ownershipOct 28, 2024Insider tradeSEC
144 · Notice of proposed saleOct 28, 2024Other filingsSEC
144 · Notice of proposed saleOct 25, 2024Other filingsSEC
4 · Change in ownershipOct 22, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedOct 22, 2024Big-stake noticeSEC
144 · Notice of proposed saleOct 22, 2024Other filingsSEC
4 · Change in ownershipOct 18, 2024Insider tradeSEC
144 · Notice of proposed saleOct 18, 2024Other filingsSEC
144 · Notice of proposed saleOct 16, 2024Other filingsSEC
4 · Change in ownershipOct 15, 2024Insider tradeSEC
144 · Notice of proposed saleOct 15, 2024Other filingsSEC
144 · Notice of proposed saleOct 11, 2024Other filingsSEC
144 · Notice of proposed saleOct 10, 2024Other filingsSEC
4 · Change in ownershipOct 8, 2024Insider tradeSEC
144 · Notice of proposed saleOct 8, 2024Other filingsSEC
144 · Notice of proposed saleOct 4, 2024Other filingsSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
144 · Notice of proposed saleOct 1, 2024Other filingsSEC
4 · Change in ownershipSep 30, 2024Insider tradeSEC
144 · Notice of proposed saleSep 30, 2024Other filingsSEC
144 · Notice of proposed saleSep 26, 2024Other filingsSEC
4 · Change in ownershipSep 23, 2024Insider tradeSEC
144 · Notice of proposed saleSep 23, 2024Other filingsSEC
144 · Notice of proposed saleSep 20, 2024Other filingsSEC
4 · Change in ownershipSep 18, 2024Insider tradeSEC
144 · Notice of proposed saleSep 17, 2024Other filingsSEC
4 · Change in ownershipAug 9, 2024Insider tradeSEC
4 · Change in ownershipAug 8, 2024Insider tradeSEC
4 · Change in ownershipAug 8, 2024Insider tradeSEC
4 · Change in ownershipAug 8, 2024Insider tradeSEC
4 · Change in ownershipAug 6, 2024Insider tradeSEC
10-Q · Quarterly reportAug 5, 2024Quarterly reportSEC
8-K · Current reportAug 5, 2024ResultsSEC
144 · Notice of proposed saleAug 5, 2024Other filingsSEC
4 · Change in ownershipJul 16, 2024Insider tradeSEC
4 · Change in ownershipJul 12, 2024Insider tradeSEC
4 · Change in ownershipJul 2, 2024Insider tradeSEC
144 · Notice of proposed saleJul 1, 2024Other filingsSEC
144 · Notice of proposed saleJul 1, 2024Other filingsSEC
4 · Change in ownershipJun 17, 2024Insider tradeSEC
144 · Notice of proposed saleJun 14, 2024Other filingsSEC
4 · Change in ownershipJun 10, 2024Insider tradeSEC
4 · Change in ownershipJun 10, 2024Insider tradeSEC
4 · Change in ownershipJun 10, 2024Insider tradeSEC
4 · Change in ownershipJun 10, 2024Insider tradeSEC
4 · Change in ownershipJun 10, 2024Insider tradeSEC
4 · Change in ownershipJun 10, 2024Insider tradeSEC

This page holds 200 of 476 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from RxSight, Inc.’s releases · as of Oct 30, 2026

Common shares
41,929,222
Fully diluted
41,929,222

Fully diluted

LineSharesAs of
Common shares41,929,222Oct 30, 2026

Share count over time

CountShares
Oct 30, 202641,929,222

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
BlackRock6.34M15.1%US$31.1MSep 30, 2026
Vanguard2.35M5.6%US$11.5MSep 30, 2026
Millennium2.14M5.1%US$10.5MSep 30, 2026
D. E. Shaw & Co., Inc.1.9M4.5%US$9.29MSep 30, 2026
No Street GP LP1.7M4.1%US$8.33MSep 30, 2026
Acadian Asset Management LLC1.45M3.5%US$7.09MSep 30, 2026
Point72 Asset Management, L.P.1.43M3.4%US$7.02MSep 30, 2026
Driehaus Capital Management LLC1.24M3.0%US$6.07MSep 30, 2026
Deep Track Capital, LP1.23M2.9%US$6.03MSep 30, 2026
Federated Hermes, Inc.1.22M2.9%US$5.96MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
AQR Capital Management LLC1.17M2.8%US$5.75MSep 30, 2026
Jacobs Levy Equity Management, Inc1.07M2.5%US$5.22MSep 30, 2026
Two Sigma918K2.2%US$4.5MSep 30, 2026
Geode Capital881K2.1%US$4.32MSep 30, 2026
State Street851K2.0%US$4.17MSep 30, 2026
UBS755K1.8%US$3.7MSep 30, 2026
Marshall Wace, LLP745K1.8%US$3.65MSep 30, 2026
Goldman Sachs613K1.5%US$3.01MSep 30, 2026
DWS536K1.3%US$2.62MSep 30, 2026
Y-Intercept (Hong Kong) Ltd477K1.1%US$2.34MSep 30, 2026
Schwab372K0.89%US$1.82MSep 30, 2026
Tudor Investment Corp Et Al354K0.84%US$1.73MSep 30, 2026
Algert Global LLC340K0.81%US$1.67MSep 30, 2026
Morgan Stanley318K0.76%US$1.56MSep 30, 2026
Northern Trust307K0.73%US$1.51MSep 30, 2026
Vitruvian Partners LLP279K0.67%US$1.37MSep 30, 2026
Citadel259K0.62%US$1.27MSep 30, 2026
Trexquant Investment LP249K0.59%US$1.22MSep 30, 2026
Renaissance Technologies227K0.54%US$1.11MSep 30, 2026
Jump Financial, LLC219K0.52%US$1.07MSep 30, 2026
Grandeur Peak Global Advisors, LLC199K0.47%US$976KSep 30, 2026
Balyasny Asset Management L.P.180K0.43%US$884KSep 30, 2026
XTX Topco Ltd177K0.42%US$866KSep 30, 2026
Moore Capital Management, LP173K0.41%US$846KSep 30, 2026
Carnegie Lake Advisors LLC153K0.36%US$748KSep 30, 2026
BNP Paribas144K0.34%US$704KSep 30, 2026
Ameriprise143K0.34%US$698KSep 30, 2026
Nuveen137K0.33%US$672KSep 30, 2026
Dimensional128K0.31%US$628KSep 30, 2026
Jane Street117K0.28%US$572KSep 30, 2026
BNY116K0.28%US$569KSep 30, 2026
Bank of America114K0.27%US$557KSep 30, 2026
Ieq Capital, LLC110K0.26%US$541KSep 30, 2026
Squarepoint Ops LLC100K0.24%US$490KSep 30, 2026
Polar Asset Management Partners Inc.100K0.24%US$490KSep 30, 2026
HSBC98,1270.23%US$478KSep 30, 2026
Russell Investments Group, Ltd.96,2080.23%US$471KSep 30, 2026
Corient Private Wealth LP90,8140.22%US$445KSep 30, 2026
Quantinno Capital Management LP88,8310.21%US$435KSep 30, 2026
Invesco84,2010.20%US$413KSep 30, 2026

This page holds 50 of 150 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund1.23M2.9%US$5.91MJun 30, 2026
iShares Russell 2000 ETF1.03M2.5%US$4.96MJun 30, 2026
Federated Hermes MDT Small Cap Core Fund646K1.5%US$3.88MJul 31, 2026
Fidelity Small Cap Index Fund434K1.0%US$2.61MJul 31, 2026
Vanguard Extended Market Index Fund409K0.98%US$1.97MJun 30, 2026
iShares Russell 2000 Value ETF336K0.80%US$1.62MJun 30, 2026
Bridge Builder Small/Mid Cap Growth Fund302K0.72%US$1.45MJun 30, 2026
BlackRock Advantage Small Cap Core Fund274K0.65%US$1.46MMay 29, 2026
North Square Dynamic Small Cap Fund228K0.54%US$1.21MMay 31, 2026
Federated Hermes MDT Small Cap Growth Fund216K0.51%US$1.3MJul 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Russell 2000 Index Fund201K0.48%US$1.07MMay 31, 2026
Grandeur Peak Global Opportunities Fund193K0.46%US$1.16MJul 31, 2026
Fidelity Extended Market Index Fund189K0.45%US$1.01MMay 31, 2026
Schwab U.S. Small-Cap ETF174K0.41%US$927KMay 31, 2026
Brown Capital Management Small Company Fund166K0.40%US$800KJun 30, 2026
Grandeur Peak Global Contrarian Fund165K0.39%US$991KJul 31, 2026
BlackRock Advantage Small Cap Growth Fund148K0.35%US$713KJun 30, 2026
iShares Micro-Cap ETF134K0.32%US$644KJun 30, 2026
Vanguard Health Care Index Fund104K0.25%US$553KMay 31, 2026
Schwab Small-Cap Index Fund93,6010.22%US$563KJul 31, 2026
Small Cap Equity Fund88,4850.21%US$426KJun 30, 2026
Master Small Cap Index Series75,3270.18%US$363KJun 30, 2026
Multi-Manager Small Cap Equity Strategies Fund64,9560.15%US$346KMay 31, 2026
Fidelity Total Market Index Fund63,8260.15%US$340KMay 31, 2026
Ultra-Small Company Market Fund60,0000.14%US$289KJun 30, 2026
Fidelity Small Cap Value Index Fund55,5750.13%US$268KJun 30, 2026
Fidelity Series Total Market Index Fund54,5400.13%US$291KMay 31, 2026
Nuveen Small Cap Blend Index Fund52,6050.13%US$316KJul 31, 2026
Diversified Equity Alpha Master Portfolio52,3670.12%US$252KJun 30, 2026
NVIT Multi-Manager Small Company Fund50,1330.12%US$242KJun 30, 2026
BlackRock Advantage SMID Cap Fund, Inc.49,1040.12%US$237KJun 30, 2026
EQ/2000 Managed Volatility Portfolio48,4770.12%US$234KJun 30, 2026
Clearwater Select Equity Fund48,3240.12%US$233KJun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF46,6960.11%US$225KJun 30, 2026
Schwab Total Stock Market Index Fund45,3480.11%US$273KJul 31, 2026
Invesco RAFI US 1500 Small-Mid ETF40,7530.10%US$245KJul 31, 2026
NVIT Small Cap Value Fund39,8000.09%US$192KJun 30, 2026
Vanguard Russell 2000 Growth Index Fund36,3370.09%US$194KMay 31, 2026
Vanguard Growth And Income Fund30,6000.07%US$147KJun 30, 2026
AVIP BlackRock Advantage Small Cap Growth Portfolio29,7880.07%US$144KJun 30, 2026
Avantis U.S. Small Cap Equity ETF29,6160.07%US$158KMay 31, 2026
EQ/Small Company Index Portfolio29,6000.07%US$143KJun 30, 2026
Strategic Advisers U.S. Total Stock Fund26,0000.06%US$139KMay 31, 2026
BlackRock Advantage SMID Cap V.I. Fund25,0830.06%US$121KJun 30, 2026
LVIP State Street Small-Cap Index Fund24,7860.06%US$119KJun 30, 2026
Nuveen Equity Index Fund24,6790.06%US$148KJul 31, 2026
Fidelity Nasdaq Composite Index Fund24,2270.06%US$129KMay 31, 2026
EQ/AB Small Cap Growth Portfolio23,5000.06%US$113KJun 30, 2026
Vanguard Balanced Index Fund23,2610.06%US$112KJun 30, 2026
Schwab U.S. Broad Market ETF21,0930.05%US$112KMay 31, 2026

This page holds 50 of 126 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Weinberg Eric
Officer: See remarks
Sale2,041USD 6.96US$14,205Sep 2, 2026
Goldshleger Ilya
Officer: Chief Operating Officer
Sale2,041USD 6.96US$14,205Sep 2, 2026
Wilterding Mark
Officer: Chief Financial Officer
Sale7,765USD 6.96US$54,044Sep 2, 2026
Kurtz Ronald M MD
Officer: Chief Medical Officer
Sale5,100USD 6.96US$35,496Sep 2, 2026

Big stakes

StakeStakeSharesDateFiling
BlackRock Portfolio Management LLC8.40%3.49MSep 30, 2026Schedule 13G
BlackRock, Inc.6.90%2.85MSep 30, 2026Schedule 13G
Millennium Management LLC5.20%2.19MNov 6, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
William J. Link
Other companies: Tarsus Pharmaceuticals, Inc. (Director · Since at least Oct 15, 2020); LENSAR, Inc. (Director · Since at least Sep 17, 2020); Oyster Point Pharma Inc (Director · Oct 30, 2019 – Jan 5, 2022 · Past); Glaukos Corporation (Director · Jun 24, 2015 – Jun 3, 2021 · Past); Vivani Medical, Inc. (Director · Nov 18, 2014 – Jun 4, 2019 · Past); Flexion Therapeutics Inc (Director · Sep 10, 2014 – Sep 10, 2014 · Past); Inogen, Inc (Director · Feb 12, 2014 – Feb 20, 2014 · Past); Edwards Lifesciences Corporation (Director · May 15, 2013 – May 8, 2020 · Past)
Director · Since at least Jul 29, 2021
Robert J. Palmisano
Other companies: AEON Biopharma, Inc. (Board Member · Since at least Feb 8, 2021); Wright Medical Group N.V (President and CEO, Director · Oct 1, 2015 – Nov 11, 2020 · Past); ev3 Inc (President and CEO, Director · Apr 6, 2008 – Jul 9, 2010 · Past); Advanced Medical Optics Inc (Director · May 22, 2007 – May 29, 2008 · Past); Osteotech Inc (Director · Jun 21, 2006 – Nov 16, 2010 · Past); Intralase Corp (President & CEO, Director · Apr 28, 2006 – Apr 2, 2007 · Past)
Director · Since at least Aug 3, 2021
Bakker Juliet Tammenoms
Other companies: CeriBell, Inc. (Director · Since at least Oct 10, 2024); Eargo, Inc. (Director · Oct 15, 2020 – May 17, 2021 · Past); Venus Concept Inc (Director · Nov 7, 2019 – Nov 7, 2019 · Past); Axonics Modulation Technologies Inc (Director · Oct 30, 2018 – Sep 18, 2020 · Past); Corcept Therapeutics Incorporated (Director · Mar 25, 2008 – Jan 21, 2011 · Past)
Director · Since at least Jul 29, 2021
Raymond W. Cohen
Other companies: InspireMD Inc. (Director · Since at least Jul 31, 2025); Kestra Medical Technologies, Ltd. (Director · Since at least Mar 6, 2025); Axonics Modulation Technologies Inc (Chief Executive Officer, Director · Oct 30, 2018 – Jan 31, 2021 · Past); BioLife Solutions, Inc. (Director · Jan 13, 2017 – Jul 12, 2021 · Past); Spectrum Pharmaceuticals Inc (Director · Jun 27, 2016 – Jun 20, 2019 · Past)
Director · Since at least Jul 31, 2025
Julie B. Andrews
Other companies: Orthofix Medical Inc. (CFO · Since at least Jan 15, 2024); AEON Biopharma, Inc. (Director · Feb 8, 2021 – Feb 8, 2021 · Past); Wright Medical Group N.V (SVP, Global Finance · Oct 1, 2015 – Nov 11, 2020 · Past)
Director · Since at least Aug 3, 2021
Aziz Mottiwala
Other companies: Tarsus Pharmaceuticals, Inc. (Chief Commercial Officer · Since at least Oct 15, 2020); Opiant Pharmaceuticals Inc (Chief Commercial Officer · Sep 20, 2019 – Sep 20, 2019 · Past)
President and Chief Executive Officer · Since at least Jul 20, 2026
Shelley Thunen
Other companies: LENZ Therapeutics, Inc. (Member · Since at least Mar 21, 2024); AEON Biopharma, Inc. (Director · Since at least Jul 21, 2023)
See remarks · Jul 29, 2021 – Apr 14, 2025 · Past
Shweta Singh Maniar
Other companies: Orthofix Medical Inc. (Director · Since at least Jan 5, 2023); SeaSpine Holdings Corp (Director · Apr 1, 2021 – Jan 5, 2023 · Past)
Director · Since at least Dec 31, 2021
Bruce Robertson
Other companies: Exagen Inc. (Director · Since at least Jun 17, 2021)
Director · Jul 29, 2021 – Aug 3, 2021 · Past
Juliet Tammenoms Bakker
Other companies: CeriBell, Inc. (Director · Since at least Nov 5, 2026)
Director · Since at least Nov 5, 2026
All 29 people
PersonSeat
Robert Warner
Other companies: Inari Medical Inc (Director · Mar 1, 2022 – Feb 19, 2025 · Past)
Director · Since at least Aug 3, 2021
Tamara R. Fountain
Other companies: Sight Sciences, Inc. (Director · Since at least Jul 15, 2022)
Director · Since at least Jan 19, 2023
Christopher CoxDirector · Jul 29, 2021 – Jul 29, 2021 · Past
Daniel Mark SchwartzDirector · Jul 29, 2021 – Aug 3, 2021 · Past
Eric WeinbergChief Business Development Officer · Since at least Jul 29, 2021
Frank ShieldsExecutive Vice President, Sales & Commercial Strategy · Since at least Nov 3, 2026
Ilya GoldshlegerChief Operating Officer · Since at least Jul 29, 2021
J. Andy CorleyChairman · Since at least Jul 15, 2026
Jesse Anderson CorleyDirector · Since at least Jul 29, 2021
Jim SchindlerExecutive Vice President & General Counsel · Since at least Nov 4, 2026
Mark WilterdingChief Financial Officer · Since at least Jan 11, 2026
Maureen O’ConnellExecutive Vice President, Clinical & Regulatory Affairs · Since at least Nov 4, 2026
Oliver MoravcevicInvestor Relations · Since at least Nov 3, 2026
Patrick CullenExecutive Vice President, Quality & Infrastructure Operations · Since at least Nov 4, 2026
Richard M WolfenDirector · Jul 29, 2021 – Aug 3, 2021 · Past
Ronald M MD KurtzChief Medical Officer · Since at least Jul 29, 2021
Ron KurtzChief Medical Officer · Since at least Jul 15, 2026
Scott GainesChief Customer Officer · Since at least Dec 18, 2025
Taryn ConwayChief Commercial Officer · Since at least Nov 3, 2026

Open People

Log in to ask 6ix AI your own questions about RxSight, Inc.